跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTELUKAST SANDOZ CHEWABLE TABLETS 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
MONTELUKAST SANDOZ CHEWABLE TABLETS 5MG
Approved
THERAPEUTIC
MONTELUKAST SANDOZ CHEWABLE TABLETS 5MG
LEK S.A. (STRYKOW) (BULK PRODUCTION) - POLANDLEK S.A. (WARSZAWA) (PRIMARY AND SECONDARY PACKAGER) (POLAND)
🇸🇬 Health Sciences Authority
Approval Date
Jul 23, 2013
Approval ID
15f925af31f64b5b
Company
LEK S.A. (STRYKOW) (BULK PRODUCTION) - POLANDLEK S.A. (WARSZAWA) (PRIMARY AND SECONDARY PACKAGER) (POLAND)
Type
Therapeutic
Approval Details
Approval Id
15f925af31f64b5b
Drug Name
MONTELUKAST SANDOZ CHEWABLE TABLETS 5MG
Product Name
MONTELUKAST SANDOZ CHEWABLE TABLETS 5MG
Approval Number
SIN14383P
Approval Date
2013-07-23
Registrant
SANDOZ SINGAPORE PTE. LTD.
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Active Ingredients
Montelukast sodium 5.20mg equivalent to montelukast
5.00mg
MONTELUKAST SODIUM 5.2 MG EQUIVALENT TO MONTELUKAST
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 23, 2013
Approval ID
15f925af31f64b5b
Type
Therapeutic
Back to HSA Approvals